Prout Samantha has filed 30 insider transactions across 1 company since August 2023.
Most recent transaction: a tax payment of 3443 shares of AMICUS THERAPEUTICS, INC. ($FOLD) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 3443 | $14.27 | 138,191.0000 | 308,533,548 | 2.43% | 0.00% |
| Jan. 3, 2026 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 12240 | $14.27 | 125,951.0000 | 308,533,548 | 8.86% | 0.00% |
| Dec. 1, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Common Stock | 32193 | $0.00 | 141,634.0000 | 308,533,548 | 29.42% | 0.01% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Common Stock | 27416 | $0.00 | 122,941.0000 | 300,116,081 | 28.70% | 0.01% |
| Feb. 11, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 13500 | $9.57 | 109,441.0000 | 300,116,081 | 10.98% | 0.00% |
| Jan. 4, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 1297 | $9.41 | 95,525.0000 | 304,380,502 | 1.34% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Stock Options (right to buy) | 62715 | $0.00 | 62,715.0000 | 304,380,502 | 9999.99% | 0.02% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 8275 | $9.41 | 96,822.0000 | 304,380,502 | 7.87% | 0.00% |
| Jan. 3, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Common Stock | 34614 | $0.00 | 105,097.0000 | 304,380,502 | 49.11% | 0.01% |
| Jan. 2, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 3443 | $9.31 | 70,483.0000 | 304,380,502 | 4.66% | 0.00% |
| April 15, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 7027 | $10.66 | 73,926.0000 | 295,164,515 | 8.68% | 0.00% |
| Jan. 8, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | S | Common Stock | 30767 | $14.00 | 82,290.0000 | 295,164,515 | 27.21% | 0.01% |
| Jan. 9, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | S | Common Stock | 1337 | $14.00 | 80,953.0000 | 295,164,515 | 1.62% | 0.00% |
| Jan. 3, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 8142 | $13.53 | 114,353.0000 | 295,164,515 | 6.65% | 0.00% |
| Jan. 4, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 1296 | $13.44 | 113,057.0000 | 295,164,515 | 1.13% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Stock Options (right to buy) | 43592 | $0.00 | 43,592.0000 | 295,164,515 | 9999.99% | 0.01% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 1313 | $14.24 | 122,495.0000 | 295,164,515 | 1.06% | 0.00% |
| Jan. 2, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | A | Common Stock | 25252 | $0.00 | 123,808.0000 | 295,164,515 | 25.62% | 0.01% |
| Dec. 31, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 23356 | $14.19 | 98,556.0000 | 289,057,198 | 19.16% | 0.01% |
| Dec. 26, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | S | Common Stock | 7659 | $14.00 | 121,912.0000 | 289,057,198 | 5.91% | 0.00% |
| Aug. 17, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | F | Common Stock | 7432 | $12.77 | 129,571.0000 | 289,057,198 | 5.42% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Common Stock | 18901 | $12.11 | 173,912.0000 | 289,057,198 | 12.19% | 0.01% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | S | Common Stock | 36909 | $14.01 | 137,003.0000 | 289,057,198 | 21.22% | 0.01% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Stock Options (right to buy) | 2376 | $0.00 | 0.0000 | 289,057,198 | 100.00% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Stock Options (right to buy) | 5040 | $0.00 | 2,526.0000 | 289,057,198 | 66.61% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Stock Options (right to buy) | 10592 | $0.00 | 3,176.0000 | 289,057,198 | 76.93% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Stock Options (right to buy) | 18901 | $0.00 | 37,810.0000 | 289,057,198 | 33.33% | 0.01% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Common Stock | 5040 | $9.55 | 144,419.0000 | 289,057,198 | 3.62% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Common Stock | 2376 | $10.04 | 139,379.0000 | 289,057,198 | 1.73% | 0.00% |
| Aug. 9, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | Prout Samantha | Chief Accounting Officer | M | Common Stock | 10592 | $10.03 | 155,011.0000 | 289,057,198 | 7.33% | 0.00% |